Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

Completed · Not applicable

Conditions studied: Hyperlipidemia, Coronary Artery Disease

In brief

The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.

Key facts

Study ID

NCT06647238

Run by

Wake Forest University Health Sciences

People needed

80

Starts

2024-11-05

Expected to finish

2025-05-27

Last updated by the study team

2025-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of coronary artery disease
• low-density lipoprotein (LDL) > 55
• Primary Care Physician at 1 of 6 identified clinics

You may not qualify if…

• Patients who are no longer an active patient of one of the internal medicine practices
• Patients whose cholesterol is managed by another practice
• Women of childbearing age/potential
• Patients residing in hospice/Long Term Care facilities
• End-stage liver disease

Where it is running

• Atrium Health Cabarrus — Concord, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.